UPLIZNA
UPLIZNA (inebilizumab-cdon) is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Neuromyelitis optica spectrum disorder
Prescribed by
Various medical specialists
How it’s administered
Intravenous (IV) infusion
Frequency
Two treatments done two weeks apart, then
one every six months
Length of treatment
90 minutes